Abstract:Trypanosoma cruzi and HIV coinfection can evolve with depression of cellular immunity and increased parasitemia. We applied quantitative PCR (qPCR) as a marker for preemptive antiparasitic treatment to avoid fatal Chagas disease reactivation and analyzed the outcome of treated cases. This mixed cross-sectional and longitudinal study included 171 Chagas disease patients, 60 coinfected with HIV. Of these 60 patients, ten showed Chagas disease reactivation, confirmed by parasites identified in the blood, cerebrospinal fluid, or tissues, 12 exhibited high parasitemia without reactivation, and 38 had low parasitemia and no reactivation. We showed, for the first time, the success of the timely introduction of benznidazole in the non-reactivated group with high levels of parasitemia detected by qPCR and the absence of parasites in reactivated cases with at least 58 days of benznidazole. All HIV+ patients with or without reactivation had a 4.0–5.1 higher chance of having parasitemia than HIV seronegative cases. A positive correlation was found between parasites and viral loads. Remarkably, treated T . cruzi/ HIV-coinfected patients had 77.3% conversion from positive to negative parasitemia compared to 19.1% of untreated patients. Additionally, untreated patients showed ~13.6 times higher Odds Ratio of having positive parasitemia in the follow-up period compared with treated patients. Treated and untreated patients showed no differences regarding the evolution of Chagas disease. The main factors associated with all-cause mortality were higher parasitemia, lower CD4 counts/μL, higher viral load, and absence of antiretroviral therapy. We recommend qPCR prospective monitoring of T . cruzi parasitemia in HIV+ coinfected patients and point out the value of pre-emptive therapy for those with high parasitemia. In parallel, early antiretroviral therapy introduction is advisable, aiming at viral load control, immune response restoration, and increasing survival. We also suggest an early antiparasitic treatment for all coinfected patients, followed by effectiveness analysis alongside antiretroviral therapy. Chagas disease, present on all continents, in HIV-infected patients with cellular immunodeficiency may lead to the multiplication of T . cruzi . Reactivation of Chagas disease is life-threatening, occurring in immunosuppressed patients and diagnosed by parasite detection in blood or tissues. Here, we employed the quantitative Polymerase Chain Reaction (qPCR) to detect the increase of parasite copies in the blood and other biological fluids. Twelve HIV-coinfected patients with increased parasitemia without reactivation and ten patients with Chagas disease reactivation were selected for antiparasitic treatment and compared with 38 HIV-coinfected untreated patients with low parasitemia. Antiparasitic treatment changed positive parasitemia to negative in 77.3% of treated patients, with or without reactivation, whereas 19% of untreated cases changed from positive to negative parasitemia, after 92 and 76 months of follow-up, respectively. Two patients with reactivation died before ten days of treatment, suggesting that the diagnosis and treatment were quite late. We recommend parasitemia monitoring by qPCR and point out the value of antiparasitic treatment to coinfected T . cruzi /HIV patients with high levels of parasites in the blood, alongside early antiretroviral introduction. We also suggest early antiparasitic treatment for all coinfected patients and the analysis of the role of benznidazole in the reduction of parasitemia and control of Chagas disease evolution.

Human Trypanosoma cruzi infection in the Argentinean Chaco: risk factors and identification of households with infected children for treatment

Trypanosoma cruzi infection in Triatoma infestans and high levels of human-vector contact across a rural-to-urban gradient in the Argentine Chaco

Humans seropositive for Trypanosoma cruzi co-infected with intestinal helminths have higher infectiousness, parasitaemia and Th2-type response in the Argentine Chaco

Domestic (re)infestation risk with the main vector Triatoma infestans increases with surrounding green vegetation and social vulnerability in the Argentine Chaco

Comparative evaluation of four rapid diagnostic tests that detect human Trypanosoma cruzi- specific antibodies to support diagnosis of Chagas Disease in urban population of Argentina

Chagas disease: lack of knowledge as a risk factor

Detecting Areas of Potential High Prevalence of Chagas in Argentina

Strongyloides stercoralis and Trypanosoma cruzi coinfections in a highly endemic area in Argentina

Characterization of Latin American migrants at risk for Trypanosoma cruzi infection in a non-endemic setting. Insights into initial evaluation of cardiac and digestive involvement

Community-based screening of Chagas disease among Latin American migrants in a non-endemic country: an observational study

Quality assurance of serologic testing for Chagas disease in a primary care setting of rural Paraguay

Pyrethroid resistance distribution in Triatoma infestans and environmental association along the Argentine endemic zone

A guide for the generation of repositories of clinical samples for research on Chagas disease

Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi /HIV coinfection

Characterization of Novel Trypanosoma cruzi-Specific Antigen with Potential Use in the Diagnosis of Chagas Disease

Molecular detection and parasite load of Trypanosoma cruzi in digestive tract tissue of Chagas disease patients affected by megacolon.

Improving Clinician Awareness of and Screening for Chagas Disease with an Educational Intervention

Seroprevalencia de Trypanosoma cruzi en niños de Veracruz, México: línea epidemiológica de base para un modelo de control fundamentado de la transmisión activa de la enfermedad de Chagas

Knowledge, Attitudes and Practices of Chagas a Neglected Tropical Disease in Rural Communities of the Colombian Caribbean, CHAGCOV Study

Spatio-temporal distribution of hospitalizations for chronic Chagas disease and risk factors associated with in-hospital mortality and surgical intervention in Chile

Exploring Trypanosoma cruzi transmission dynamics in an acute Chagas disease outbreak using next-generation sequencing